650-999 West Broadway
Member Sector: Medical Devices
LightIntegra Technology Inc. is developing ThromboLUX, a medical device that analyzes the quality of platelets immediately prior to a transfusion. Platelets are a key component of blood, and necessary for clotting, however 17% of platelet transfusions are ineffective due to low-quality platelets. ThromboLUX will be the first point-of-care device that makes a rapid determination of platelet quality, thus avoiding ineffective transfusions. This fast-to-market device promises to improve patient outcomes and safety while lowering health care costs.